Sanguinarine Attenuates Lung Cancer Progression via Oxidative Stress-induced Cell Apoptosis.

Apoptosis Cytometry. Flow Lung cancer Reactive oxygen species Sanguinarine Vegf

Journal

Current molecular pharmacology
ISSN: 1874-4702
Titre abrégé: Curr Mol Pharmacol
Pays: United Arab Emirates
ID NLM: 101467997

Informations de publication

Date de publication:
2024
Historique:
received: 07 08 2023
revised: 09 09 2023
accepted: 20 09 2023
medline: 23 2 2024
pubmed: 23 2 2024
entrez: 23 2 2024
Statut: ppublish

Résumé

Lung cancer (LC) incidence is rising globally and is reflected as a leading cause of cancer-associated deaths. Lung cancer leads to multistage carcinogenesis with gradually increasing genetic and epigenetic changes. Sanguinarine (sang) mediated the anticancer effect in LCC lines by involving the stimulation of reactive oxygen species (ROS), impeding Bcl2, and enhancing Bax and other apoptosis-associated protein Caspase-3, -9, and -PARP, subsequently inhibiting the LC invasion and migration. This study was conducted to investigate the apoptotic rate and mechanism of Sang in human LC cells (LCC) H522 and H1299. MTT assay to determine the IC Sang significantly inhibited the growth of LCC lines in both time- and dose-dependent fashions. Flow cytometry examination and Annexin-V labeling determined that Sang increased the apoptotic cell percentage. H522 and H1299 LCC lines treated with Sang showed distinctive characteristics of apoptosis, including morphological changes and DNA fragmentation. Sang exhibited anticancer potential in LCC lines and could induce apoptosis and impede the invasion and migration of LCC, emerging as a promising anticancer natural agent in lung cancer management.

Sections du résumé

BACKGROUND BACKGROUND
Lung cancer (LC) incidence is rising globally and is reflected as a leading cause of cancer-associated deaths. Lung cancer leads to multistage carcinogenesis with gradually increasing genetic and epigenetic changes.
AIMS OBJECTIVE
Sanguinarine (sang) mediated the anticancer effect in LCC lines by involving the stimulation of reactive oxygen species (ROS), impeding Bcl2, and enhancing Bax and other apoptosis-associated protein Caspase-3, -9, and -PARP, subsequently inhibiting the LC invasion and migration.
OBJECTIVE OBJECTIVE
This study was conducted to investigate the apoptotic rate and mechanism of Sang in human LC cells (LCC) H522 and H1299.
METHODS METHODS
MTT assay to determine the IC
RESULTS RESULTS
Sang significantly inhibited the growth of LCC lines in both time- and dose-dependent fashions. Flow cytometry examination and Annexin-V labeling determined that Sang increased the apoptotic cell percentage. H522 and H1299 LCC lines treated with Sang showed distinctive characteristics of apoptosis, including morphological changes and DNA fragmentation.
CONCLUSION CONCLUSIONS
Sang exhibited anticancer potential in LCC lines and could induce apoptosis and impede the invasion and migration of LCC, emerging as a promising anticancer natural agent in lung cancer management.

Identifiants

pubmed: 38389415
pii: CMP-EPUB-138287
doi: 10.2174/0118761429269383231119062233
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e18761429269383

Subventions

Organisme : Deanship of Scientific Research at King Khalid University
ID : R.G.P. 2/ 59 /44

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Asmat Ullah (A)

Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang, China.

Anum Razzaq (A)

College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.

Mohammad Y Alfaifi (MY)

King Khalid University, Faculty of Science, Biology Department, Abha 9004, Saudi Arabia.

Serag Eldin I Elbehairi (SEI)

King Khalid University, Faculty of Science, Biology Department, Abha 9004, Saudi Arabia.

Farid Menaa (F)

Departments of Oncology and Nanomedicine, California Innovations Corporation, San Diego, CA 92037, USA.

Najeeb Ullah (N)

Department of Biomedical Engineering, Louisiana Tech University, Ruston, LA, 818 Nelson Ave, 71272, USA.

Somia Shehzadi (S)

University Institute of Medical Laboratory Technology, The University of Lahore, Lahore 54000, Pakistan.

Touseef Nawaz (T)

Faculty of Pharmacy, Gomal University, D.I. Khan, 29050, Pakistan.

Haroon Iqbal (H)

Zhejiang Cancer Hospital, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences Hangzhou, Zhejiang 310022, China.

Classifications MeSH